Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 121-130 of 271 for Lung cancer

Edit search filters
  1. A Safety Study Of SEA-TGT (SGN-TGT) In Patients With Advanced Cancer

    Rochester, MN

  2. Study Of Pembrolizumab (MK-3475) In Participants With Relapsed Or Refractory Primary Mediastinal Large B-cell Lymphoma Or Relapsed Or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170)

    Rochester, MN

  3. A Pilot, Randomized, Open-label Study Of Tumor Treating Fields (TTFields, 150 KHz) Concomitant With Pembrolizumab For First Line Treatment Of Advanced Or Metastatic Non-small Cell Lung Cancer

    Scottsdale/Phoenix, AZ

  4. A Dose Escalation And Confirmation Study Of PT-112 In Advanced Solid Tumors In Combination With Avelumab

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. Study Of Oraxol And Pembrolizumab In Subjects With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Metformin As A Chemoprevention Agent In Non-small Cell Lung Cancer

    Rochester, MN

  7. Dignity Therapy/Life Plan In Patients With Pancreatic Or Advanced Lung Cancer

    Rochester, MN

  8. A Study To Evaluate Whether Probiotics For Gut Microbiome Will Target Cancer Immune Microenvironment In Breast And Lung Cancer

    Jacksonville, FL

  9. Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer

    La Crosse, WI

  10. Study Of NXP900 With Osimertinib In Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer